Ranbaxy gains nearly 1% as FDA approves Gurgaon & Romania R&D centres

Subscribe to GoodReturns

Ranbaxy gains nearly 1% as FDA approves Gurgaon & Romania R&D centres
Shares of Ranbaxy Laboratories Ltd. fell nearly 1 per cent in early trade on Bombay Stock Exchange (BSE) after reports suggested that US drug regulator inspected its two centres in Gurgaon & Romania R&D and cleared it.

The shares of company fell as much as 0.88 per cent to trade at Rs 471 a piece on the BSE. In a similar fashion, shares of the company fell 1.07 per cent to Rs 472.35 a piece on National Stock Exchange. Meanwhile, the broader benchmark Sensex was quoting at 22,717.06, up 14.72 points or 0.06 per cent at 10:27 hours.

Dion Global Solutions Ltd.

Read more about: ranbaxy laboratories, sensex, bse, fda
Story first published: Thursday, April 10, 2014, 12:46 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'